Nicotinamide Riboside Enhances Walking Distance in PAD Patients

Author Profile Image

- Updated by Jody Mullis
Medically reviewed by Dr. Sidra Samad

 

Why This Matters to Us

As longevity enthusiasts, we are always on the lookout for interventions that can improve the quality of life and healthspan. Peripheral artery disease (PAD) is a common circulatory problem that impacts many individuals, leading to pain and reduced mobility due to poor blood flow to the limbs. This study is particularly interesting because it examines how a compound called nicotinamide riboside (NR) can improve the symptoms of PAD, offering potential benefits for cardiovascular health and overall longevity.

What This Study Showed

Study Background: This study explored whether nicotinamide riboside (NR), an over-the-counter supplement that increases levels of NAD+ in the body, could enhance walking performance and reduce symptoms in people with peripheral artery disease (PAD). NR boosts NAD+, a vital coenzyme involved in numerous biological processes, including energy metabolism and cellular repair.

Key Findings: The study involved 90 people with PAD who were randomly assigned to take NR, NR combined with another supplement called resveratrol, or a placebo over six months. Researchers measured the participants' walking distance using a six-minute walk test at both the beginning and end of the study period.

Results showed that the group taking NR alone significantly improved their six-minute walk distance compared to the placebo group. Specifically, participants on NR walked an average of 7 meters more, whereas the placebo group walked 10.6 meters less, translating to an overall improvement of 17.6 meters in favor of the NR group.

Further analysis showed that the benefits were even more pronounced among participants who adhered strictly to the regimen, taking at least 75% of their study pills. In these individuals, NR improved the six-minute walk distance by 31 meters, while the combination of NR and resveratrol improved it by approximately 27 meters.

Why These Findings Are Exciting: Understanding how NR can improve mobility and reduce PAD symptoms provides valuable insight into how we might enhance cardiovascular health and extend functional lifespan. These results suggest that NR could be a simple, effective intervention to boost physical performance and overall quality of life for individuals suffering from PAD.

Scientific Terms Explained:

  • Nicotinamide Riboside (NR): A form of vitamin B3 that increases the levels of NAD+, which is essential for energy production and cellular repair.
  • NAD+ (Nicotinamide Adenine Dinucleotide): A coenzyme required for many critical processes in the body, including energy metabolism and the repair of damaged cells.
  • Peripheral Artery Disease (PAD): A condition where narrowed blood vessels reduce blood flow to the limbs, causing pain and mobility issues.
  • Six-Minute Walk Test: A simple exercise test that measures the distance a person can walk in six minutes as a way to assess their functional exercise capacity.

The findings from this study highlight the potential of nicotinamide riboside to improve the health and mobility of individuals with PAD, offering a new avenue for enhancing longevity and quality of life. Given the significant improvements in walking distance, NR supplementation could become a valuable tool in the management of PAD and possibly other age-related conditions affecting the vascular system.

For more details, you can read the full text of the study here.